A new treatment vertical in eye care, pharmacologic agents for refractive correction, is in the early stage of ...

Tenpoint Therapeutics’ Yuvezzi gets US FDA nod; the first and only combo eye drop approved to treat presbyopia: London Saturday, January 31, 2026, 14:00 Hrs [IST] Tenpoint Thera ...

In Lenz Therapeutics’ new eye drop campaign, Sarah Jessica Parker serves as a brand ambassador for the over-40 audience.

YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S.

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

The FDA has approved a first-of-its-kind eye drop that addresses a common vision condition. The once-daily drops will treat an age-related condition that causes blurry near vision. The drops are ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults with presbyopia. This age-related condition affects more than 100 million ...

In a quiet but potentially transformative development for millions of Americans, the U.S. Food and Drug Administration (FDA) has approved a new type of daily eye drop that restores near vision without ...

The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision loss in mice with an inherited eye disease. In mice both with retinitis ...